29 related articles for article (PubMed ID: 38737731)
1. The presence of circulating genetically abnormal cells in blood predicts risk of lung cancer in individuals with indeterminate pulmonary nodules.
Tahvilian S; Kuban JD; Yankelevitz DF; Leventon D; Henschke CI; Zhu J; Baden L; Yip R; Hirsch FR; Reed R; Brown A; Muldoon A; Trejo M; Katchman BA; Donovan MJ; Pagano PC
BMC Pulm Med; 2023 Jun; 23(1):193. PubMed ID: 37277788
[TBL] [Abstract][Full Text] [Related]
2. Cell-free DNA assay for malignancy classification of high-risk lung nodules.
Wang S; Meng F; Chen P; Lv Y; Wu M; Tang H; Bao H; Wu X; Shao Y; Wang J; Dai J; Xu L; Wang X; Yin R
J Thorac Cardiovasc Surg; 2024 Apr; ():. PubMed ID: 38670484
[TBL] [Abstract][Full Text] [Related]
3. Deep Learning Models for Predicting Malignancy Risk in CT-Detected Pulmonary Nodules: A Systematic Review and Meta-analysis.
Wulaningsih W; Villamaria C; Akram A; Benemile J; Croce F; Watkins J
Lung; 2024 May; ():. PubMed ID: 38782779
[TBL] [Abstract][Full Text] [Related]
4. A clinical-information-free method for early diagnosis of lung cancer from the patients with pulmonary nodules based on backpropagation neural network model.
Yang X; Wu C; Liu W; Fu K; Tian Y; Wei X; Zhang W; Sun P; Luo H; Huang J
Comput Struct Biotechnol J; 2024 Dec; 24():404-411. PubMed ID: 38813092
[TBL] [Abstract][Full Text] [Related]
5. A Real-World Assessment of Stage I Lung Cancer Through Electronic Nose Technology.
Rocco G; Pennazza G; Tan KS; Vanstraelen S; Santonico M; Corba RJ; Park BJ; Sihag S; Bott MJ; Crucitti P; Isbell JM; Ginsberg MS; Weiss H; Incalzi RA; Finamore P; Longo F; Zompanti A; Grasso S; Solomon SB; Vincent A; McKnight A; Cirelli M; Voli C; Kelly S; Merone M; Molena D; Gray K; Huang J; Rusch VW; Bains MS; Downey RJ; Adusumilli PS; Jones DR
J Thorac Oncol; 2024 May; ():. PubMed ID: 38762120
[TBL] [Abstract][Full Text] [Related]
6. The Lung Cancer Prediction Model "Stress Test": Assessment of Models' Performance in a High-Risk Prospective Pulmonary Nodule Cohort.
Heideman BE; Kammer MN; Paez R; Swanson T; Godfrey CM; Low SW; Xiao D; Li TZ; Richardson JR; Knight MA; Shojaee S; Deppen SA; Lentz RJ; Grogan EL; Maldonado F
CHEST Pulm; 2024 Mar; 2(1):. PubMed ID: 38737731
[TBL] [Abstract][Full Text] [Related]
7. The Thoracic Research Evaluation and Treatment 2.0 Model: A Lung Cancer Prediction Model for Indeterminate Nodules Referred for Specialist Evaluation.
Godfrey CM; Shipe ME; Welty VF; Maiga AW; Aldrich MC; Montgomery C; Crockett J; Vaszar LT; Regis S; Isbell JM; Rickman OB; Pinkerman R; Lambright ES; Nesbitt JC; Maldonado F; Blume JD; Deppen SA; Grogan EL
Chest; 2023 Nov; 164(5):1305-1314. PubMed ID: 37421973
[TBL] [Abstract][Full Text] [Related]
8. Cancer statistics, 2022.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2022 Jan; 72(1):7-33. PubMed ID: 35020204
[TBL] [Abstract][Full Text] [Related]
9. The Probability of Lung Cancer in Patients With Incidentally Detected Pulmonary Nodules: Clinical Characteristics and Accuracy of Prediction Models.
Vachani A; Zheng C; Amy Liu IL; Huang BZ; Osuji TA; Gould MK
Chest; 2022 Feb; 161(2):562-571. PubMed ID: 34364866
[TBL] [Abstract][Full Text] [Related]
10. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.
de Koning HJ; van der Aalst CM; de Jong PA; Scholten ET; Nackaerts K; Heuvelmans MA; Lammers JJ; Weenink C; Yousaf-Khan U; Horeweg N; van 't Westeinde S; Prokop M; Mali WP; Mohamed Hoesein FAA; van Ooijen PMA; Aerts JGJV; den Bakker MA; Thunnissen E; Verschakelen J; Vliegenthart R; Walter JE; Ten Haaf K; Groen HJM; Oudkerk M
N Engl J Med; 2020 Feb; 382(6):503-513. PubMed ID: 31995683
[TBL] [Abstract][Full Text] [Related]
11. Models to Estimate the Probability of Malignancy in Patients with Pulmonary Nodules.
Choi HK; Ghobrial M; Mazzone PJ
Ann Am Thorac Soc; 2018 Oct; 15(10):1117-1126. PubMed ID: 30272500
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of Models to Identify Lung Nodule Cancer Risk in the National Lung Screening Trial.
Nair VS; Sundaram V; Desai M; Gould MK
Am J Respir Crit Care Med; 2018 May; 197(9):1220-1223. PubMed ID: 29064264
[No Abstract] [Full Text] [Related]
13. Development and validation of a nomogram to estimate the pretest probability of cancer in Chinese patients with solid solitary pulmonary nodules: A multi-institutional study.
She Y; Zhao L; Dai C; Ren Y; Jiang G; Xie H; Zhu H; Sun X; Yang P; Chen Y; Shi S; Shi W; Yu B; Xie D; Chen C
J Surg Oncol; 2017 Nov; 116(6):756-762. PubMed ID: 28570780
[TBL] [Abstract][Full Text] [Related]
14. Multicenter external validation of two malignancy risk prediction models in patients undergoing 18F-FDG-PET for solitary pulmonary nodule evaluation.
Perandini S; Soardi GA; Larici AR; Del Ciello A; Rizzardi G; Solazzo A; Mancino L; Zeraj F; Bernhart M; Signorini M; Motton M; Montemezzi S
Eur Radiol; 2017 May; 27(5):2042-2046. PubMed ID: 27631108
[TBL] [Abstract][Full Text] [Related]
15. Costs of Diagnostic Assessment for Lung Cancer: A Medicare Claims Analysis.
Lokhandwala T; Bittoni MA; Dann RA; D'Souza AO; Johnson M; Nagy RJ; Lanman RB; Merritt RE; Carbone DP
Clin Lung Cancer; 2017 Jan; 18(1):e27-e34. PubMed ID: 27530054
[TBL] [Abstract][Full Text] [Related]
16. Recent Trends in the Identification of Incidental Pulmonary Nodules.
Gould MK; Tang T; Liu IL; Lee J; Zheng C; Danforth KN; Kosco AE; Di Fiore JL; Suh DE
Am J Respir Crit Care Med; 2015 Nov; 192(10):1208-14. PubMed ID: 26214244
[TBL] [Abstract][Full Text] [Related]
17. The British Thoracic Society guidelines on the investigation and management of pulmonary nodules.
Baldwin DR; Callister ME;
Thorax; 2015 Aug; 70(8):794-8. PubMed ID: 26135833
[TBL] [Abstract][Full Text] [Related]
18. Risk of malignancy in pulmonary nodules: A validation study of four prediction models.
Al-Ameri A; Malhotra P; Thygesen H; Plant PK; Vaidyanathan S; Karthik S; Scarsbrook A; Callister ME
Lung Cancer; 2015 Jul; 89(1):27-30. PubMed ID: 25864782
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
